Targeting lipoproteins to Fc gamma receptors with bispecific antibodies
- PMID: 8581385
- DOI: 10.1089/scd.1.1995.4.457
Targeting lipoproteins to Fc gamma receptors with bispecific antibodies
Abstract
The data presented here support use of bispecific antibodies (BsAb) for studying the role of each of the different types of IgG Fc receptors (Fc gamma Rs) in uptake and metabolism of low-density lipoprotein (LDL) immune complexes. The bispecific anti-Fc gamma R x anti-LDL antibodies used in these studies were effective in specifically triggering metabolic uptake and degradation of LDL immune complexes (LDL-IC) through each type of Fc gamma R. Using LDL-IC prepared with LDL aggregates, foam cell formation was induced with relatively acute stimulation. Thus, these conditions will be appropriate for studying lipoprotein metabolism in the context of specific Fc gamma R under a variety of conditions to determine if, in fact, there are differences in sterol metabolism associated with the different types of Fc gamma R and for comparing metabolism to that mediated by the other important pathways of lipoprotein uptake (native LDL receptors and scavenger receptors). The results of these studies will reveal which of these pathways are potentially most important in foam cell formation and might suggest the possibility that macrophage foam cell formation could be altered by redirecting LDL to particular pathways.
Similar articles
-
Enhanced metabolism of LDL aggregates mediated by specific human monocyte IgG Fc receptors.J Lipid Res. 1995 Apr;36(4):714-24. J Lipid Res. 1995. PMID: 7616118
-
Redirected targeting of LDL to human monocyte Fc gamma receptors with bispecific antibodies.Arterioscler Thromb. 1992 Oct;12(10):1131-8. doi: 10.1161/01.atv.12.10.1131. Arterioscler Thromb. 1992. PMID: 1390585
-
Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL.Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3248-54. doi: 10.1161/01.atv.17.11.3248. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409319
-
Production and use of anti-FcR bispecific antibodies.Immunomethods. 1994 Feb;4(1):72-81. doi: 10.1006/immu.1994.1009. Immunomethods. 1994. PMID: 8069530 Review.
-
Factors influencing the endocytosis of immune complexes.Adv Nephrol Necker Hosp. 1984;13:341-67. Adv Nephrol Necker Hosp. 1984. PMID: 6236677 Review.